30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Performance

Overall performance
3.7

Performance over holding periods
3.7
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Oscient Pharmaceuticals Corp March 19, 2003 -
Independent Trustee Tekla Life Sciences Investors Jan. 1, 2010 -
Independent Trustee Tekla Healthcare Investors June 8, 2010 -
Independent Trustee Tekla World Healthcare Fund Jan. 1, 2015 -
Independent Trustees Tekla Healthcare Opportunities Fund Jan. 1, 2014 -
Lead Independent Director Idera Pharmaceuticals Inc Sept. 1, 2010 - March 10, 2019
Independent Director Madrigal Pharmaceuticals Inc Aug. 1, 2004 - July 22, 2016

William Reardon's trades of Tekla World Healthcare Fund's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-03-01 2021-02-25 B Purchase
6,725 -27.8%
496.90
US$2,309,370
6,725 -27.8% 496.90 US$2,309,370
2021-03-01 2021-02-25 B Purchase
6,653 +19.6%
53.55
US$2,592,244
6,653 +19.6% 53.55 US$2,592,244
2014-07-01 2014-06-30 B Purchase
821 -0.0%
42.66
US$3,689,979
821 -0.0% 42.66 US$3,689,979
2013-11-15 2013-11-13 B Purchase
13,333 +57.4%
3.75
US$49,999
13,333 +57.4% 3.75 US$49,999
2012-03-12 2012-03-09 B Purchase
646 +inf%
15.86
US$10,242
646 +inf% 15.86 US$10,242
2012-03-12 2012-03-09 B Purchase
772 +inf%
13.27
US$10,241
772 +inf% 13.27 US$10,241
2004-07-12 2004-07-08 B Purchase
5,974 +115.8%
0.54
US$3,250
5,974 +115.8% 0.54 US$3,250